Vol. 12, Special Issue 9 (2023)

Background: The main aim of this study is to conduct an assessment of the drug utilization evaluation of anxiolytics and antidepressants in CVD patients. And to estimate the quality of life of the patients using the WHO-QOL BREF questionnaire.

Results: The distribution of drugs was studied among the 97 patients, and it was found that antiplatelet agents were the most commonly prescribed drugs among CVD patients. The most commonly prescribed anxiolytics and antidepressants among the CVD patients were found to be benzodiazepines. Using the WHO-QOL BREF questionnaire to assess patient quality of life, this study discovered that DOM1, or physical health, graded the highest among the other four categories.

Conclusion: The study showed that advancing age was the predominating risk factor for causing anxiety and depression among CVD patients. In CVD patients, benzodiazepines were the most commonly prescribed anxiolytics. The WHOQOL-BREF was used to assess the quality of life and found that the physical domain remains the highest among the other domains. This indicated healthy daily activities, a reduced dependence on medications and medical devices, adequate energy and mobility, a lower level of pain and discomfort, adequate sleep and rest, and good working capacity.